FIELD: biotechnology.
SUBSTANCE: methods include contacting of a biofilm comprising one or more of Staphylococcus or Streptococcus, with a composition comprising an effective amount of a lysin polypeptide comprising the amino acid sequence of SEQ ID NO: 1 or versions thereof having at least 80% identity to the SEQ ID NO: 1 polypeptide and being effective for staphylococcal and streptococcal bacteria lysis in a biofilm. The biofilm is effectively dispersed or treated. The inventions allow to eliminate not only mature biofilms, but also to prevent formation of de novo biofilms.
EFFECT: lysin polypeptide used demonstrates high activity at lower concentrations compared to the lack of activity of antibiotics used at high concentrations.
21 cl, 21 dwg, 7 tbl, 14 ex
Title | Year | Author | Number |
---|---|---|---|
PREVENTION, DESTRUCTION AND TREATMENT OF BIOFILM BY BACTERIOPHAGE LYSINE | 2013 |
|
RU2735103C2 |
COMBINATIONS OF BACTERIOPHAGE LYSINE AND ANTIBIOTICS AGAINST GRAM-POSITIVE BACTERIA | 2013 |
|
RU2659208C2 |
METHOD FOR MICRO-DILUTION IN LIQUID MEDIUM FOR EVALUATING AND DETERMINING MINIMUM INHIBITORY CONCENTRATION OF ANTIBACTERIAL POLYPEPTIDES | 2017 |
|
RU2754667C2 |
STRAIN OF BACTERIOPHAGE Staphylococcus aureus SA20 ENSURING DESTRUCTION OF BIOFILMS CREATED BY BACTERIA OF Staphylococcus FAMILY | 2014 |
|
RU2565824C1 |
RECOMBINANT PLASMID DNA pQE-70_LysAP46 PROVIDING SYNTHESIS OF RECOMBINANT PROTEIN LysAP46, STRAIN OF ESCHERICHIA COLI BACTERIA - PRODUCER OF RECOMBINANT PROTEIN LysAP46 AND RECOMBINANT PROTEIN LysAP46, WHICH HAS ANTIBACTERIAL EFFECT | 2022 |
|
RU2809842C1 |
MODIFIED ENDOLYSIN AND ANTIBACTERIAL COMPOSITIONS BASED THEREON FOR TREATING INFECTIONS CAUSED BY ACINETOBACTER BAUMANNII, PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI BACTERIA | 2023 |
|
RU2813626C1 |
INHIBITION OF BIOFILM ORGANISMS | 2010 |
|
RU2548786C2 |
COMBINED THERAPIES | 2016 |
|
RU2725800C2 |
ACINETOBACTER LYSINES | 2015 |
|
RU2725809C2 |
SPECIES-SPECIFIC BACTERIOPHAGE STRAIN HAVING LYTIC ACTIVITY IN RELATION TO Staphylococcus aureus, INCLUDING MULTI-DRUG RESISTANT STRAINS | 2012 |
|
RU2503716C1 |
Authors
Dates
2018-03-01—Published
2013-05-09—Filed